Meclizine for Hepatocellular Carcinoma
Clinical trial NCT03253289 · COMPLETED
Trial details
- NCT number
- NCT03253289
- Sponsor
- Tannaz Armaghnay
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-13
- Primary completion
- 2023-03-28
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.